CLINICAL AND EPIDEMIOLOGICAL FACTORS DETERMINING PROPAGATION AND CLINIC OF UROGENITAL TRICHOMONIASIS IN WOMEN

Cover Page


Cite item

Full Text

Abstract

The problem of urogenital trichomoniasis (UGT) is relevant not only due to its high prevalence and multiple organ lesions, but also to the ability to have a negative impact on reproductive health. In Kazakhstan, UGT is one of the leading infections in the structure of sexually transmitted infections: in 2011 51.5%; 2012 — 43.5%; 2013 — 42.0% with the prevalence of co-infection with other STIs, in which the rate of complications is increased by 2 times and are more profound with the involvement of inflammation in the upper urogenital tract. The recorded incidence of trichomoniasis in the RK is characterized by annual rate decrease (since 2011 a 1.5 times decrease) due to small fluctuations of syphilis, gonorrhea, chlamydia morbidity which indicates a large reservoir of latent infection, and low level of diagnostics. Most clearly demonstrates this situation an incidence of UGT in 2 cities: so in Astana in 2013, the recorded incidence decreased by 2.8 times compared to 2011; in Almaty — 6 times in 2012 and 4.3 times in 2013. Conducted clinical and epidemiological analysis of UGT morbidity in women allowed to identify the following: in recent years the tendency of UGT to growth with a significant proportion of latent asymptomatic forms (for more than one quarter of patients with UGT, UGT is most common in young adults, average age 30.5±2.5 years); in half of the cases recorded, mixed trichomonas infection, mostly in combination with Chlamydia, which causes a high incidence of complications of the upper urogenital tract; there is a high frequency of trichomonas infection combination with infections caused by Candida, mycoplasma, which determines the prospects of the combination therapy UGT in combination with drugs, correcting immunodeficiency. There is quite a high incidence of gynecological pathology, the severity of which depends on the frequency of the spectrum of pathogens that are associated with T. vaginalis. The data obtained allows to select women with trichomonas infection of the urogenital tract with the complication risk that affect the reproductive function; UGT develops together with urogenital tract disbacteriosis with a predominance of Staphylococcus species, having adhesive, lizotsimogenic, hemolytic activity that must be considered when conducting a combined therapy with drugs, correcting microflora. The frequency of various complications was significantly higher in patients with mixed infection. Particular attention is drawn to the attention of the high frequency of adnexitis, uterine fibroids, their rate was equivalent to and higher than the corresponding figures of 1.9 times and 5 times, respectively (38.0% versus 20.0% and 7.8%, p < 0,05) at monoinfection. In this group of ovarian cyst recorded in 10.1% of cases. Basically, the above-mentioned diseases were observed in patients with trichomonas, chlamydial infection. Adnexitis and uterine fibroids in all 30 cases were recorded in patients co-infected with this that has made 75,0±6,8%. Our findings are consistent with studies of high risk of pelvic inflammatory disease in women with trichomoniasis. Other studies have reported increases of 1.9 times the risk of tubal infertility in women with trichomoniasis. Trichomoniasis can also play a role in cervical neoplasia and postoperative infections.

About the authors

K. S. Akyshbayeva

Kazakh National Medical University named after S.D. Asfendiyarov, Almaty, Republic of Kazakhstan

Author for correspondence.
Email: azuritlO@mail.ru

PhD, MD (Medicine), Professor of the Department of Microbiology, Virology and Immunology, Kazakh National Medical University named after S.D. Asfendiyarov, Almaty, Republic of Kazakhstan 050000, Republic of Kazakhstan, Almaty, Tole bi str., 88, Phone: +7 (727) 388-70-80 (office); + 7 701 707-96-45 (mobile)

Россия

S. M. Nurusheva

Kazakh National Medical University named after S.D. Asfendiyarov, Almaty, Republic of Kazakhstan

Email: fake@neicon.ru

PhD, MD (Medicine), Professor, Head of the Department of Dermatovenereology, Kazakh National Medical University named after S.D. Asfendiyarov, Almaty, Republic of Kazakhstan

Россия

L. T. Almenova

Kazakh National Medical University named after S.D. Asfendiyarov, Almaty, Republic of Kazakhstan

Email: fake@neicon.ru

PhD (Medicine), Associate Professor, Department of Dermatovenereology, Kazakh National Medical University named after S.D. Asfendiyarov, Almaty, Republic of Kazakhstan

Россия

References

  1. Горчаков Д.А., Луцевич И.Н., Софьина А.В., Софьин В.С. Лекарственная устойчивость Т. vaginalis как проявление наследуемой модификационной изменчивости у простейших // Фундаментальные исследования. 2012. № 12 (часть 1). С. 40–43. [Gorchakov D.A., Lutsevich I.N., Sofina A.V., Sofin V.S. Drug resistance T. vaginalis as a manifestation of an inherited modification variability in the simplest. Fundamental’nye issledovaniya = Basic Research, 2012, no. 12 (part 1). pp. 40–43. (In Russ.)]
  2. Клименко Б.В., Авазов Э.Р., Барановская В.Б. Трихомониаз у мужчин, женщин и детей. СПб.: Сюжет: Русская графика, 2001. 183 с. [Klimenko B.V., Avazov E.R., Baranovskaya V.B. Trikhomoniaz u muzhchin, zhenshchin i detei [Trichomoniasis in men, women and children]. SPb.: Syuzhet: Russkaya grafika, 2001, 183 p.]
  3. Кобзева А.В. Экспериментальное изучение развития резистентности Trichomonas vaginalis к противопротозойным препаратам // Бюллетень медицинских Интернет-конференций. 2012. T. 2, № 2. [Kobzeva A.V. Experimental study of Trichomonas vaginalis resistance to antiprotozoal drugs. Byulleten’ meditsinskikh Internet-konferentsii = Bulletin of Medical Internet Conference, 2012, vol. 2, no. 2, p. 69. (In Russ.)]
  4. Мавров Г.И. Половые болезни: руководство для врачей, интернов и студентов. Харьков: Факт, 2003. 789 с. [Mavrov G.I. Polovye bolezni: rukovodstvo dlya vrachei, internov i studentov [Sexual disease: guidelines for physicians, interns and students]. Kharkov: Fact, 2003, 789 p.]
  5. Мавров Г.И., Осинская Т.В. Проблемы трихомонадной инфекции у беременных и новорожденных: эпидемиология, особенности клиники, диагностики, лечения и профилактики // Український журнал дерматології, венерології, косметології. 2007. № 2. C. 74–78. [Mavrov G.I., Osynskaya T.V. Problems trichomonas infection in pregnant women and newborns: epidemiology, clinical features, diagnosis, treatment and prevention. Ukraїns’kii zhurnal dermatologії, venerologії, kosmetologії = Ukrainian Journal of Dermatology, Venereology, Cosmetology, 2007, no. 2, pp. 74–78. (In Russ.)]
  6. Охапкин М.Б., Хитров М.В., Ильяшенко И.Н. Инфекционные заболевания в акушерстве и гинекологии: пособие для врачей и интернов. Ярославль: ЯГМА, 2003. 12 с. [Ohapkin M.B., Hitrov M.V., Ilyashenko I.N. Infektsionnye zabolevaniya v akusherstve i ginekologii: posobie dlya vrachei i internov [Infectious diseases are in obstetrics and gynecology: manual for doctors and interns]. Yaroslavl: YaGMA, 2003, 12 p.]
  7. Рахматулина М.Р. Новые возможности терапии урогенитальных инфекционных заболеваний // Урология, гинекология, дерматовенерология. 2007. № 10. С. 26–31. [Rahmatulina M.R. New possibilities of therapy of urogenital infectious diseases. Urologiya, ginekologiya, dermatovenerologiya = Urology, Gynecology, Dermatovenerology, 2007, no. 10, pp. 26–31. (In Russ.)]
  8. Рыжко П.П. Современные принципы комплексной терапии трихомонадной и хламидийной инфекций // Жіночий лікар. 2008. № 3. С. 26. [Rizhko P.P. Modern principles of complex therapy of trichomonas and chlamydial infections. Zhіnochij lіkar = Female Doctor, 2008, no. 3, p. 26. (In Russ.)]
  9. Серов В.Н. Современные принципы профилактики и лечения воспалительных заболеваний женских половых органов в оперативной и неоперативной гинекологии: методические рекомендации для врачей акушеров-гинекологов. М., 2005. 52 с. [Serov V.N. Sovremennye printsipy profilaktiki i lecheniya vospalitel’nykh zabolevanii zhenskikh polovykh organov v operativnoi i neoperativnoi ginekologii: metodicheskie rekomendatsii dlya vrachei akusherov-ginekologov [Modern principles of prevention and treatment of inflammatory diseases of the female genital organs in the operational and non-operational gynecology: guidelines for obstetricians and gynecologists]. Moscow, 2005. 52 p.]
  10. Халдин А.А. Современное состояние проблемы негонококковых уретритов и перспективы их терапии // Российский журнал кожных и венерических болезней. 2004. № 3. С. 42–45. [Haldin A.A. Current status of non-gonococcal urethritis and prospects for therapy. Rossiiskii zhurnal kozhnykh i venericheskikh boleznei = Russian Journal of Skin and Venereal Diseases, 2004, no. 3, pp. 42–45. (In Russ.)]
  11. Шкарупета М.М., Копылов В.М., Байцур М.В., Портнова Н.И. Урогенитальный трихомониаз: пособие для врачей, 5-е изд. (перераб. и доп.) / Под общ. ред. В.М. Говоруна. М.: 2009. 55 c. [Shkarupeta M.M., Kopylov V.M., Baytsur M.V., Portnova N.I. Urogenital’nyi trikhomoniaz: posobie dlya vrachei, 5-e izd. (pererab. i dop.) [Urogenitaly Trichomoniasis: manual for physicians, 5th ed. (rev., and exp.) / Ed. by V.M. Govorun]. Moscow, 2009. 55 p.]
  12. Bachmann L.H., Hobbs M.M., Seña A.C., Sobel J.D., Schwebke J.R., Krieger J.N., McClelland R.S., Workowski K.A. Trichomonas vaginalis genital infections: progress and challenges. Clin. Infect. Dis., vol. 53, suppl. 3, pp. 160–172. doi: 10.1093/cid/cir705
  13. Bell C., Hough E., Smith A., Greene L. Targeted screening for Trichomonas vaginalis in women, a pH-based approach. Int. J. STD AIDS, 2007, vol. 18, no. 6, pp. 402–403.
  14. Brogly S.B., Watts D.H., Ylitalo N., Franco E.L., Seage G.R.3rd, Oleske J., Eagle M., Van Dyke R. Reproductive health of adolescent girls perinatally infected with HIV. Am. J. Publ. Health, 2007, vol. 97, pp. 1047–1052. doi: 10.2105/AJPH.2005.071910
  15. Fouts A.C., Kraus S.J. Trichomonas vaginalis: reevaluation of its clinical presentation and laboratory diagnosis. J. Infect. Dis., 1980, vol. 141, no. 2, pp. 137–143. doi: 10.1093/infdis/141.2.137
  16. Garcia A., Exposto F., Prieto E., Lopes M., Duarte A., Correia da Silva R. Association of Trichomonas vaginalis with sociodemographic factors and other STDs among female inmates in Lisbon. Int. J. STD AIDS, 2004, vol. 15, no. 9, pp. 615–618.
  17. Gehrig S., Efferth T. Development of drug resistance in Trichomonas vaginalis and its overcoming with natural products. The Open Bioactive Compounds Journal, 2009, vol. 2, pp. 21–28. doi: 10.2174/1874847300902010021
  18. Grodstein F., Goldman M.B., Ryan L., Cramer D.W. Relation of female infertility to consumption of caffeinated beverages. Am. J. Epidemiol., 1993, vol. 137, no. 12, pp. 1353–1360.
  19. Huppert J.S. Trichomoniasis in teens: an update. Curr. Opin. Obstet. Gynecol., 2009, vol. 21, no. 5, pp. 371–378. doi: 10.1097/GCO.0b013e32832e0827
  20. Johnston V.J., Mabey D.C. Global epidemiology and control of Trichomonas vaginalis. Curr. Opin. Infect. Dis., 2008, vol. 21, pp. 56–64. doi: 10.1097/QCO.0b013e3282f3d999
  21. Joyner J.L., Douglas J.M., Ragsdale S., Foster M., Judson F.N. Comparative prevalence of infection with Trichomonas vaginalis among men attending a sexually transmitted diseases clinic. Sex. Transm. Dis., 2000, vol. 27, no. 4, pp. 236–240.
  22. Kalichman S.C., Pellowski J., Turner C. Prevalence of sexually transmitted co-infections in people living with HIV/AIDS: systematic review with implications for using HIV treatments for prevention. Sex. Transm. Infect., 2011, vol. 87, pp. 183–190. doi: 10.1136/sti.2010.047514
  23. Kirkcaldy R.D., Augostini P., Asbel L.E., Bernstein K.T., Kerani R.P., Mettenbrink C.J., Pathela P., Schwebke J.R., Secor W.E., Workowski K.A., Davis D., Braxton J., Weinstock H.S. Trichomonas vaginalis antimicrobial drug resistance in 6 US cities, STD Surveillance Network, 2009–2010. Emerg. Infect. Dis., 2012, vol. 18, no. 6, pp. 939–943. doi: 10.3201/eid1806.111590
  24. Kissinger P., Amedee A., Clark R.A., Dumestre J., Theall K.P., Myers L., Hagensee M.E., Farley T.A., Martin D.H. Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding. Sex. Transm. Dis., 2009, vol. 36, no. 1, pp. 11–16. doi: 10.1097/OLQ.0b013e318186decf
  25. Kissinger P., Adamski A. Trichomoniasis and HIV interactions: a review. Sex. Transm. Infect., 2013, vol. 89, no. 6, pp. 426–433. doi: 10.1136/sextrans-2012-051005
  26. McClelland R.S., Sangare L., Hassan W.M., Lavreys L., Mandaliya K., Kiarie J., Ndinya-Achola J., Jaoko W., Baeten J.M. Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. J. Infect. Dis., 2007, vol. 195, no. 5, pp. 698–702. doi: 10.1086/511278
  27. Miller M., Liao Y., Wagner M., Korves C. HIV, the clustering of sexually transmitted infections, and sex risk among African American women who use drugs. Sex. Transm. Dis., 2008, vol. 35, no. 7, pp. 696–702. doi: 10.1097/OLQ.0b013e31816b1fb8
  28. Miller W.C., Swygard H., Hobbs M.M., Ford C.A., Handcock M.S., Morris M., Schmitz, J.L., Cohen M.S., Harris K.M., Udry J.R. The prevalence of trichomoniasis in young adults in the United States. Sex. Transm. Dis., 2005, vol. 32, no. 10, pp. 593–598.
  29. Petrin D., Delgaty K., Bhatt R., Garber G. Clinical and microbiological aspects of Trichomonas vaginalis. Clin. Microbiol. Rev., 1998, vol. 11, no. 2, pp. 300–317.
  30. Ryan K.A., Zekeng L., Roddy R.E., Weer S.S. Prevalence and prediction of sexually transmitted disease among sex workers in Cameroon. Int. J. STD AIDS, 1998, vol. 9, no. 7, pp. 403–407.
  31. Schwebke J.R., Burgess D. Trichomoniasis. Clin. Microbiol. Rev., 2004, vol. 17, no. 4, pp. 794–803. doi: 10.1128/CMR.17.4.794-803.2004
  32. Sobel J.D. What’s new in bacterial vaginosis and trichomoniasis? Infect. Dis. Clin. North. Am., 2005, vol. 19, no. 2, pp. 387–406. doi: 10.1016/j.idc.2005.03.001
  33. Soper D. Trichomoniasis: under control or undercontrolled? Am. J. Obstet. Gynecol., 2004, vol. 190, no. 1, pp. 281–290.
  34. Soper D.E., Bump R.C., Hurt W.G. Bacterial vaginosis and trichomoniasis vaginitis are risk factors for cuff cellulitis after abdominal hysterectomy. Am. J. Obstet. Gynecol., 1990, vol. 163, no. 3, pp. 1016–1021.
  35. Sutton M., Sternberg M., Koumans E.H., McQuillan G., Berman S., Markowitz L. The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001–2004. Clin. Infect. Dis., 2007, vol. 45, no. 10, pp. 1319–1326. doi: 10.1086/522532
  36. Sayed el-Ahl S.A., el-Wakil H.S., Kamel N.M., Mahmoud M.S. A preliminary study on the relationship between Trichomonas vaginalis and cervical cancer in Egyptian women. J. Egypt Soc. Parasitol., 2002, vol. 32, no. 1, pp.167–178.
  37. Wang C.C., McClelland R.S., Reilly M., Overbaugh J., Emery S.R., Mandaliya K., Chohan B., Ndinya-Achola J., Bwayo J., Kreiss J.K. The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1. J. Infect. Dis., 2001, vol. 183, no. 7, pp. 1017–1022. doi: 10.1086/319287
  38. Watts D.H., Fazzari M., Minkoff H., Hillier S.L., Sha B., Glesby M., Levine A.M., Burk R., Palefsky J.M., Moxley M., Ahdieh-Grant L., Strickler H.D. Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women. J. Infect. Dis., 2005, vol. 191, no. 7, pp. 1129–1139. doi: 10.1086/427777
  39. Watts D.H., Springer G., Minkoff H., Hillier S.L., Jacobson L., Moxley M., Justman J., Cejtin H., O’Connell C., Greenblatt R.M. The occurrence of vaginal infections among HIV-infected and high-risk HIV-uninfected women: longitudinal findings of the women’s interagency HIV study. J. Acquir. Immun. Defic. Syndr., 2006, vol. 43, no. 2, pp. 161–168.
  40. Wolner-Hanssen P., Krieger J.N., Stevens C.E., Kiviat N.B., Koutsky L., Critchlow C., DeRouen T., Hillier S., Holmes K.K. Clinical manifestations of vaginal trichomoniasis. JAMA, 1989, vol. 261, no. 4, pp. 571–576.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2016 Akyshbayeva K.S., Nurusheva S.M., Almenova L.T.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 64788 от 02.02.2016.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies